Expertise in
1
conditions

Dr. Bryan J. Wolf

Rheumatology
Sierra Nevada Rheumatology LLC
6165 Ridgeview Ct Ste C, 
Reno, NV 
Accepting New Patients
Referral may be required
Before you request
Expertise in
1
conditions
Sierra Nevada Rheumatology LLC
6165 Ridgeview Ct Ste C, 
Reno, NV 

Overview

Bryan Wolf is a Rheumatologist practicing medicine in Reno, Nevada.

Dr. Wolf is highly rated in 1 condition, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, and Relapsing Polychondritis.

He is actively involved in clinical research, participating in 11 clinical trials. Dr. Wolf is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in NV

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Sierra Nevada Rheumatology LLC
6165 Ridgeview Ct Ste C, Reno, NV 89519

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
19
conditions
Expertise in
19
conditions
Referral required
Before you request

Carson Tahoe Rheumatology-Reno

10539 Professional Cir Ste 200, 
Reno, NV 
 (11.0 miles away)
775-445-5193
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anjani Pillarisetty is a Rheumatologist practicing medicine in Reno, Nevada. Dr. Pillarisetty is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Sarcoidosis, Lupus Nephritis, Neurosarcoidosis, and Raynaud Phenomenon. Dr. Pillarisetty is currently accepting new patients.

Expertise in
40
conditions
Expertise in
40
conditions
Referral required
Before you request

Carson Valley Medical Center Rural Health Clinic

897 Ironwood Dr, 
Minden, NV 
 (36.0 miles away)
775-782-1610
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Susan Knowles is a Rheumatologist practicing medicine in Minden, Nevada. Dr. Knowles is highly rated in 40 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Sjogren Syndrome, Psoriatic Arthritis, and Undifferentiated Connective Tissue Disease (UCTD). Dr. Knowles is board certified in American Board Of Internal Medicine. Dr. Knowles is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required
Before you request

Arthritis Consultants

160 Country Estates Cir Ste 2, 
Reno, NV 
 (6.7 miles away)
775-322-9100
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Scully is a Rheumatologist practicing medicine in Reno, Nevada. Dr. Scully is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Lupus Nephritis, Inclusion Body Myositis, and Systemic Sclerosis (SSc). Dr. Scully is board certified in American Board Of Internal Medicine. Dr. Scully is currently accepting new patients.

Frequently Asked Questions about Dr. Bryan J. Wolf

How do I make an appointment with Dr. Bryan J. Wolf?

You can book an appointment with Dr. Bryan J. Wolf by calling their office at 775-824-9454. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Bryan J. Wolf a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bryan J. Wolf is classified as an Advanced expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Bryan J. Wolf specialize in?

While Dr. Bryan J. Wolf is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, and Rhizomelic Pseudopolyarthritis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Bryan J. Wolf accept my insurance?

Dr. Bryan J. Wolf accepts most major insurance plans, including Humana. We recommend calling the office directly at 775-824-9454 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wolf's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile